Top Dividend Stocks To Watch Now – February 10th

Direxion Daily TSLA Bull 2X Shares, Merck & Co., Inc., BP, ProShares UltraPro Short QQQ, Exxon Mobil, Pfizer, and Bristol-Myers Squibb are the seven Dividend stocks to watch today, according to MarketBeat’s stock screener tool. Dividend stocks are publicly traded companies that pay out a portion of their earnings to shareholders in the form of dividends. These stocks are often sought after by investors seeking regular income and long-term growth potential. These companies had the highest dollar trading volume of any Dividend stocks within the last several days.

Direxion Daily TSLA Bull 2X Shares (TSLL)

TSLL stock traded down $0.81 during midday trading on Monday, reaching $20.32. The company had a trading volume of 60,598,379 shares, compared to its average volume of 63,224,230. The stock has a 50 day moving average price of $28.29 and a 200-day moving average price of $18.08. The company has a market capitalization of $3.93 billion, a price-to-earnings ratio of 40.38 and a beta of -5.14. Direxion Daily TSLA Bull 2X Shares has a 1-year low of $4.94 and a 1-year high of $41.50.

Merck & Co., Inc. (MRK)

Merck & Co., Inc. is a health care company, which engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. It operates through the following segments: Pharmaceutical, Animal Health, and Other. The Pharmaceutical segment includes human health pharmaceutical and vaccine products.

NYSE MRK traded down $0.88 on Monday, reaching $86.41. The company had a trading volume of 14,163,066 shares, compared to its average volume of 13,648,654. The company’s fifty day moving average is $98.72 and its 200 day moving average is $106.34. The company has a quick ratio of 1.15, a current ratio of 1.36 and a debt-to-equity ratio of 0.79. Merck & Co., Inc. has a 52-week low of $86.36 and a 52-week high of $134.63. The stock has a market capitalization of $218.57 billion, a P/E ratio of 12.84, a P/E/G ratio of 0.83 and a beta of 0.38.

BP (BP)

BP p.l.c. provides carbon products and services. The company operates through Gas & Low Carbon Energy, Oil Production & Operations, and Customers & Products segments. It engages in the production of natural gas, and integrated gas and power; trading of gas; operation of onshore and offshore wind power, as well as hydrogen and carbon capture and storage facilities; trading and marketing of renewable and non-renewable power; and production of crude oil.

NYSE BP traded up $2.32 on Monday, hitting $34.59. The stock had a trading volume of 30,124,088 shares, compared to its average volume of 11,651,802. The company has a market capitalization of $92.59 billion, a price-to-earnings ratio of 36.48, a price-to-earnings-growth ratio of 2.26 and a beta of 0.64. The company has a debt-to-equity ratio of 0.66, a quick ratio of 0.94 and a current ratio of 1.22. The firm has a 50-day moving average of $30.36 and a 200-day moving average of $31.34. BP has a 52-week low of $27.82 and a 52-week high of $40.40.

ProShares UltraPro Short QQQ (SQQQ)

ProShares UltraPro Short QQQ (the Fund) seeks daily investment results, which corresponds to three times the inverse of the daily performance of the NASDAQ-100 Index (the Index). The Index includes 100 of the non-financial domestic and international issues listed on National Association of Securities Dealers Automated Quotation (NASDAQ) Stock Market.

Shares of ProShares UltraPro Short QQQ stock traded down $1.11 during trading on Monday, reaching $27.82. 36,636,213 shares of the stock were exchanged, compared to its average volume of 54,007,688. ProShares UltraPro Short QQQ has a 1 year low of $27.23 and a 1 year high of $64.95. The stock’s fifty day moving average is $29.67 and its 200 day moving average is $35.95.

Exxon Mobil (XOM)

Exxon Mobil Corporation engages in the exploration and production of crude oil and natural gas in the United States and internationally. It operates through Upstream, Energy Products, Chemical Products, and Specialty Products segments. The Upstream segment explores for and produces crude oil and natural gas.

Shares of XOM traded up $1.77 during mid-day trading on Monday, hitting $110.66. 6,557,624 shares of the company traded hands, compared to its average volume of 14,631,135. The stock has a 50-day moving average price of $109.41 and a two-hundred day moving average price of $114.97. The stock has a market cap of $486.36 billion, a price-to-earnings ratio of 14.11, a P/E/G ratio of 2.94 and a beta of 0.89. Exxon Mobil has a 1 year low of $100.42 and a 1 year high of $126.34. The company has a debt-to-equity ratio of 0.14, a quick ratio of 0.97 and a current ratio of 1.31.

Pfizer (PFE)

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States, Europe, and internationally. The company offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic, migraine, and women's health under the Eliquis, Nurtec ODT/Vydura, Zavzpret, and the Premarin family brands; infectious diseases with unmet medical needs under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and COVID-19 prevention and treatment, and potential future mRNA and antiviral products under the Comirnaty and Paxlovid brands.

Shares of PFE traded up $0.21 during midday trading on Monday, hitting $25.95. 26,508,891 shares of the company traded hands, compared to its average volume of 38,264,355. The stock has a market cap of $147.03 billion, a price-to-earnings ratio of 18.39, a PEG ratio of 0.64 and a beta of 0.64. Pfizer has a 52 week low of $24.48 and a 52 week high of $31.54. The company has a debt-to-equity ratio of 0.63, a quick ratio of 0.73 and a current ratio of 1.00. The firm has a 50 day moving average of $26.28 and a 200-day moving average of $27.72.

Bristol-Myers Squibb (BMY)

Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, and neuroscience diseases. The company's products include Eliquis for reduction in risk of stroke/systemic embolism in non-valvular atrial fibrillation, and for the treatment of DVT/PE; Opdivo for various anti-cancer indications, including bladder, blood, CRC, head and neck, RCC, HCC, lung, melanoma, MPM, stomach and esophageal cancer; Pomalyst/Imnovid for multiple myeloma; Orencia for active rheumatoid arthritis and psoriatic arthritis; and Sprycel for the treatment of Philadelphia chromosome-positive chronic myeloid leukemia.

Shares of BMY stock traded down $1.44 during mid-day trading on Monday, hitting $55.41. The stock had a trading volume of 11,302,587 shares, compared to its average volume of 10,903,718. The firm’s 50-day moving average is $57.56 and its two-hundred day moving average is $53.89. Bristol-Myers Squibb has a 12-month low of $39.35 and a 12-month high of $61.10. The firm has a market capitalization of $112.38 billion, a P/E ratio of -12.53, a price-to-earnings-growth ratio of 2.13 and a beta of 0.45. The company has a debt-to-equity ratio of 2.83, a current ratio of 1.24 and a quick ratio of 1.09.